200423-remdesivir-gilead-se-207p_de0c450b9d24370b51594c4da9a3b306.jpg

  • June 18, 2020
  • 0
  • 4 Views

FILE – In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)


Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com